NCT05679388 2024-09-19
A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients
University of Chicago
Phase 1 Terminated
Clinical Trials
5 trialsNCT01787331 2020-02-05
Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer
University of California, San Francisco
Phase 2 Completed
NCT00887458 2017-10-16
A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy
Johns Hopkins University
Phase 2 Completed
NCT01450683 2017-04-11
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
Stanford University
Phase 2 Terminated
NCT02054793 2014-07-23
Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC)
Johns Hopkins University
Phase 1/2 Withdrawn